Joint (JYNT) EBITDA (2013 - 2026)

Joint (JYNT) posted EBITDA of $873668.0 for Q1 2026, up 17.68% sequentially from $742410.0 in Q4 2025, and up 228.76% YoY from $265747.9 in Q1 2025.

Analysis

Joint (JYNT) EBITDA (2013 - 2026) Analysis & Trends

Joint has reported EBITDA for 14 years, with the latest figure at $873668.0 in Q1 2026.

Quarterly EBITDA rose 228.76% year-over-year to $873668.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $638826.0 (up 129.84% YoY) and the FY2025 annual result came in at -$913376.0, up 51.65% from the prior year.
EBITDA improved to $873668.0 in Q1 2026 per JYNT's latest filing, from $742410.0 in the prior quarter.
Over five years, EBITDA peaked at $994643.0 in Q4 2023 and troughed at -$1.8 million in Q2 2024.
A 5-year average of -$205850.5 and a median of -$257890.0 in 2023 frame the typical range for EBITDA.
The sharpest annual moves came in 2024 and 2026: EBITDA tumbled 12811.19% in 2024, then surged 228.76% in 2026.
Over 5 years, EBITDA stood at -$1.3 million in 2022, then soared by 179.43% to $994643.0 in 2023, then decreased by 18.59% to $809716.0 in 2024, then fell by 8.31% to $742410.0 in 2025, then rose by 17.68% to $873668.0 in 2026.
According to Business Quant data, EBITDA over the past three periods registered $873668.0, $742410.0, and $160915.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EBITDA (Qtr)
1	HCA Healthcare	90.36 Bn	89.35 Bn	15.19 Bn	-2.55 Bn
2	Tenet Healthcare	22.02 Bn	19.85 Bn	4.45 Bn	1.50 Bn
3	Encompass Health	12.13 Bn	11.99 Bn	1.34 Bn	33.50 Mn
4	Davita	11.78 Bn	11.09 Bn	1.16 Bn	579.00 Mn
5	Universal Health Services	10.09 Bn	9.95 Bn	3.29 Bn	516.68 Mn
6	Ensign	9.97 Bn	9.65 Bn	306.24 Mn	122.50 Mn
7	Chemed	6.93 Bn	6.89 Bn	221.47 Mn	103.47 Mn
8	Pacs	6.81 Bn	6.64 Bn	338.46 Mn	109.33 Mn
9	Concentra Group Holdings Parent	4.32 Bn	4.16 Bn	192.10 Mn	115.07 Mn
10	Joint	117.66 Mn	95.51 Mn	12.70 Mn	-368,657.00

Historic Data

Download Data